EU clinches BioNTech/Pfizer vaccine deal with 1.8B doses

The EU has announced a deal with BioNTech/Pfizer for up to 1.8 billion extra doses of their Covid-19 vaccine.

The contract, on top of the 600 million BioNTech/Pfizer doses the commission has already secured, aims to supply the bloc with enough vaccines for booster shots, the EU Commission said on Saturday.

The EU said it could also expand vaccinations to minors and for exports to lower-income countries outside the bloc.

Comments